Phase 3 trials are clinical trials that are done to see if an experimental drug or treatment works better, or has fewer side effects than the standard treatment for a condition. Treatments that are being evaluated in phase 3 trials have already been tested in phase 1 clinical trials (trials to look at safety), and phase 2 trials (trials done to see of a treatment works).
Phase 3 trials are often “double-blind” clinical trials, that is, neither the researchers nor the patients know if individuals are receiving the experimental treatment or the standard treatment.
Further Reading:



